Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema INTELLIPHARMACEUTICS

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
19.03.IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics lists on NEX7
13.03.IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics stuck on NEX over disclosures2
13.03.Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan314TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
► Artikel lesen
07.03.Intellipharmaceutics International Inc. - 6-K, Report of foreign issuer2
06.03.IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics receives cease trade order2
06.03.Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Cease Trade Order496TORONTO, ON / ACCESSWIRE / March 6, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research...
► Artikel lesen
06.03.IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics International halted at the open2
27.02.Intellipharmaceutics International Inc. - 6-K, Report of foreign issuer1
27.02.Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form367TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
► Artikel lesen
08.02.IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics grants options to buy 1.91M shares-
08.02.Intellipharmaceutics International Inc. Announces Stock Option Grant356TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
► Artikel lesen
03.01.Intellipharmaceutics receives conditional approval to list on the TSX Venture Exchange3
02.01.IntelliPharmaCeutics International Inc (2): IntelliPharmaCeutics receives cond. OK to list on TSX-V1
02.01.Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange519TORONTO, ON / ACCESSWIRE / January 2, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
► Artikel lesen